These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients. Benitez-Rosario MA; Martin AS; Feria M J Pain Symptom Manage; 2005 Nov; 30(5):395-7. PubMed ID: 16310612 [No Abstract] [Full Text] [Related]
3. The use of nebulized fentanyl for the management of dyspnea. Coyne PJ Clin J Oncol Nurs; 2003; 7(3):334-5. PubMed ID: 12793342 [No Abstract] [Full Text] [Related]
4. Inhaled nebulized and intranasal opioids for the relief of breathlessness. Bausewein C; Simon ST Curr Opin Support Palliat Care; 2014 Sep; 8(3):208-12. PubMed ID: 25004175 [TBL] [Abstract][Full Text] [Related]
5. Intranasal fentanyl for acute pain: techniques to enhance efficacy. Wolfe T Ann Emerg Med; 2007 May; 49(5):721-2. PubMed ID: 17452275 [No Abstract] [Full Text] [Related]
6. Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient. Graff GR; Stark JM; Grueber R Respiration; 2004; 71(6):646-9. PubMed ID: 15627879 [TBL] [Abstract][Full Text] [Related]
7. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial. Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508 [TBL] [Abstract][Full Text] [Related]
8. Fentanyl in the prehospital setting. Thomas SH Am J Emerg Med; 2007 Sep; 25(7):842-3. PubMed ID: 17870493 [No Abstract] [Full Text] [Related]
9. [Nasal application of fentanyl citrate as symptom control against breathlessness in palliative care--overview and case report]. Sitte T Wien Med Wochenschr; 2009 Dec; 159(23-24):566-70. PubMed ID: 20151344 [TBL] [Abstract][Full Text] [Related]
10. Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned. Smith TJ; Coyne P; French W; Ramakrishnan V; Corrigan P J Palliat Med; 2009 Sep; 12(9):771-2. PubMed ID: 19719370 [No Abstract] [Full Text] [Related]
11. Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea. Pang GS; Qu LM; Tan YY; Yee AC Am J Hosp Palliat Care; 2016 Apr; 33(3):222-7. PubMed ID: 25425740 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [TBL] [Abstract][Full Text] [Related]
13. Intranasal Fentanyl Versus Placebo for Treatment of Episodic Breathlessness in Hospice Patients With Advanced Nonmalignant Diseases. Iupati S; Bridge R; Allan S; Hewitt D J Pain Symptom Manage; 2021 May; 61(5):1035-1041. PubMed ID: 33186729 [TBL] [Abstract][Full Text] [Related]
14. The Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study. Pilkey J; Pedersen A; Tam JW; Malik A; Wong J J Palliat Care; 2019 Apr; 34(2):96-102. PubMed ID: 29848173 [TBL] [Abstract][Full Text] [Related]